These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 16644901)
1. Neuroproteomics of the synapse and drug addiction. Abul-Husn NS; Devi LA J Pharmacol Exp Ther; 2006 Aug; 318(2):461-8. PubMed ID: 16644901 [TBL] [Abstract][Full Text] [Related]
2. Synapse proteomics: current status and quantitative applications. Li KW; Jimenez CR Expert Rev Proteomics; 2008 Apr; 5(2):353-60. PubMed ID: 18466062 [TBL] [Abstract][Full Text] [Related]
3. Proteomics in the study of hippocampal plasticity. Cobb SR; Pitt A Expert Rev Proteomics; 2008 Jun; 5(3):393-404. PubMed ID: 18532907 [TBL] [Abstract][Full Text] [Related]
6. A review of current applications of mass spectrometry for neuroproteomics in epilepsy. Liu X; Wen F; Yang J; Chen L; Wei YQ Mass Spectrom Rev; 2010; 29(2):197-246. PubMed ID: 19598206 [TBL] [Abstract][Full Text] [Related]
7. Functional genomics and proteomics in the clinical neurosciences: data mining and bioinformatics. Phan JH; Quo CF; Wang MD Prog Brain Res; 2006; 158():83-108. PubMed ID: 17027692 [TBL] [Abstract][Full Text] [Related]
8. Use of proteomics for the identification of novel drug targets in brain diseases. Morón JA; Devi LA J Neurochem; 2007 Jul; 102(2):306-15. PubMed ID: 17419802 [TBL] [Abstract][Full Text] [Related]
9. Role of orexin/hypocretin and CRF in the formation of drug-dependent synaptic plasticity in the mesolimbic system. Bonci A; Borgland S Neuropharmacology; 2009; 56 Suppl 1():107-11. PubMed ID: 18694770 [TBL] [Abstract][Full Text] [Related]
10. Synapse proteomics of multiprotein complexes: en route from genes to nervous system diseases. Grant SG; Marshall MC; Page KL; Cumiskey MA; Armstrong JD Hum Mol Genet; 2005 Oct; 14 Spec No. 2():R225-34. PubMed ID: 16150739 [TBL] [Abstract][Full Text] [Related]
12. The synapse proteome and phosphoproteome: a new paradigm for synapse biology. Grant SG Biochem Soc Trans; 2006 Feb; 34(Pt 1):59-63. PubMed ID: 16417483 [TBL] [Abstract][Full Text] [Related]
13. Glutamate receptor plasticity at excitatory synapses in the brain. Genoux D; Montgomery JM Clin Exp Pharmacol Physiol; 2007 Oct; 34(10):1058-63. PubMed ID: 17714094 [TBL] [Abstract][Full Text] [Related]
14. The systems view in addiction research. Gebicke-Haerter PJ; Tretter F Addict Biol; 2008 Sep; 13(3-4):449-54. PubMed ID: 18782387 [TBL] [Abstract][Full Text] [Related]
15. Immunoisolation and subfractionation of synaptic vesicle proteins. Burré J; Zimmermann H; Volknandt W Anal Biochem; 2007 Mar; 362(2):172-81. PubMed ID: 17266918 [TBL] [Abstract][Full Text] [Related]
16. Proteomic analysis of rat prefrontal cortex in three phases of morphine-induced conditioned place preference. Yang L; Sun ZS; Zhu YP J Proteome Res; 2007 Jun; 6(6):2239-47. PubMed ID: 17444669 [TBL] [Abstract][Full Text] [Related]
17. Integrating synapse proteomics with transcriptional regulation. Valor LM; Grant SG Behav Genet; 2007 Jan; 37(1):18-30. PubMed ID: 16977502 [TBL] [Abstract][Full Text] [Related]
18. The neuroproteomics of schizophrenia. English JA; Pennington K; Dunn MJ; Cotter DR Biol Psychiatry; 2011 Jan; 69(2):163-72. PubMed ID: 20887976 [TBL] [Abstract][Full Text] [Related]
19. Molecular dynamics of postsynaptic receptors and scaffold proteins. Renner M; Specht CG; Triller A Curr Opin Neurobiol; 2008 Oct; 18(5):532-40. PubMed ID: 18832033 [TBL] [Abstract][Full Text] [Related]
20. A neuroeconomic theory of bidirectional synaptic plasticity and addiction. Takahashi T Med Hypotheses; 2010 Oct; 75(4):356-8. PubMed ID: 20395061 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]